About Stavanger Helseforskning
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Stavanger Helseforskning
During the past decade, Stavanger Helseforskning conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-small Cell Lung Cancer
2000-10-01
2019-11-01
Completed
1,772
Four Versus Six Cycles of Cyclophosphamide/Doxorubicin or Paclitaxel in Adjuvant Breast Cancer
2002-05-01
2014-06-01
Completed
3,871
Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer
2002-12-01
2016-12-01
Completed
546
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
2004-08-15
Active, not recruiting
406
Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma
2005-03-01
2014-01-01
Completed
175
Pentostatin, Cyclophosphamide, and Rituximab Followed By Campath-1H in Patients With Relapsed or Refractory B-Cell CLL
2004-12-16
2018-05-06
Completed
102
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Stavanger Helseforskning"
#1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Stavanger Helseforskning
According to Clinical.Site data, the most researched conditions in "Stavanger Helseforskning" are
"Atrial Fibrillation" (1 trials), "Congestive Heart Failure" (1 trials), "Diabetes Mellitus, Type 1" (1 trials) and "Percutaneous Coronary Intervention" (1 trials). Many other conditions were trialed in "Stavanger Helseforskning" in a lesser frequency.
Clinical Trials Intervention Types at Stavanger Helseforskning
Most popular intervention types in "Stavanger Helseforskning" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Aspirin" (1 trials), "Clopidogrel or Ticagrelor" (1 trials), "Dabigatran Etexilate 110mg" (1 trials), "Dabigatran Etexilate 150mg" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Stavanger Helseforskning
The vast majority of trials in "Stavanger Helseforskning" are
3 trials for "All" genders.
Clinical Trials Status at Stavanger Helseforskning
Currently, there are NaN active trials in "Stavanger Helseforskning".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Stavanger Helseforskning,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Stavanger Helseforskning, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".